14 El-Salhy M. Gastrointestinal transit in nonobese diabetic mouse: an animal model of human diabetes type 1. J Diabetes Complications 2001; 15: 277-284 15 Van Assche G, Depoortere I. Contractile effects and intracellular Ca2+ signalling induced by motilin and erythromycin in the circular smooth muscle of human colon. Neurogastroenterol Motil 2001; 13: 27-35 16 Nakanome C, Akai H, Hongo M, Imai N, Toyota T, Goto Y, Okuguchi F, Komatsu K. Disturbances of the alimentary tract motility and hypermotilinemia in the patients with diabetes mellitus. Tohoku J Exp Med 1983; 139: 205-215 17 Vazeou A, Papadopoulou A, Papadimitriou A, Kitsou E, Stathatos M, Bartsocas CS. Autonomic neuropathy and gastrointestinal motility disorders in children and adolescents with type 1 diabetes mellitus. J Pediatr Gastroenterol Nutr 2004; 38: 61-65 18 吴波, 韩萍, 周卓. 糖尿病胃肠病脑肠肽的相关性. 广东医学 2004; 11: 1297-1299 19 Kunt T, Forst T, Schmidt S, Pfutzner A, Schneider S, Harzer O, Lobig M, Engelbach M, Goitom K, Pohlmann T, Beyer J. Serum levels of substance P are decreased in patients with type 1 diabetes. Exp Clin Endocrinol Diabetes 2000; 108: 164-167 20 El-Salhy M. Neuroendocrine peptides of the gastrointestinal tract of an animal model of human type 2 diabetes mellitus. Acta Diabetol 1998; 35: 194-198 21 El-Salhy M, Spangeus A. Substance P in the gastrointestinal tract of non-obese diabetic mice. Scand J Gastroenterol 1998; 33: 394-400 郑正荣, 杨春康, 戴起宝, 福建医科大学附属第一医院肿瘤外科 福建省福州市 350005 福建省卫生厅创新课题基金资助课题, No.2003-X-13 通讯作者: 杨春康, 350005, 福建省福州市,福建医科大学附属第一医院肿瘤外科. chuankang129@yahoo.com.cn 电话: 0591-87982562 (责任编辑:泉水) |